Article info
PDFLetter
ABO blood groups and severe outcomes in COVID-19: A meta-analysis
- Correspondence to Dr Sukrita Bhattacharjee, Department of Hematology, Institute of Hematology and Transfusion Medicine, Medical College and Hospital Kolkata, Kolkata 700073, India; skrtbhttchry{at}gmail.com
Citation
ABO blood groups and severe outcomes in COVID-19: A meta-analysis
Publication history
- Accepted December 7, 2020
- First published December 24, 2020.
Online issue publication
March 01, 2022
Article Versions
- Previous version (24 December 2020).
- Previous version (14 October 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.